MentionFox
Home › Outlook Therapeutics, Inc. › team
Company · named in SEC filings

Outlook Therapeutics, Inc. founders and team

11 people are named across 6 of Outlook Therapeutics, Inc.'s SEC filings, with the role each filing states.

Funding historyFounders and team

What do you want to do with Outlook Therapeutics, Inc.?

NameRole stated in the filingNamed in
Andong HuangDirector2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Faisal SukhtianDirector2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Gerd AuffarthDirector2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Julian GangolliDirector2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Kurt HilzingerDirector2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Lawrence KenyonExecutive Officer, Director2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Randy ThurmanDirector2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Yezan HaddadinDirector2026-05-07, 2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Julia HallerDirector2025-01-27, 2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
C. TrenaryExecutive Officer, Director2024-04-16, 2024-03-29, 2023-01-06, 2023-01-06
Jeff EvansonExecutive Officer2025-01-27, 2024-04-16, 2024-03-29

Want the whole picture on Outlook Therapeutics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Outlook Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Outlook Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    5 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

Names and roles exactly as the filings list them: executive officers, directors and promoters. Nothing here is inferred, and a filing only lists the people it is required to.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Outlook Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/outlook-therapeutics-inc/team
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Outlook Therapeutics, Inc. founders and team (from SEC filings). MentionFox, 2026-09-27. https://mentionfox.com/company/outlook-therapeutics-inc/team